Basal Insulin as a Foundation of Diabetes Treatments: Innovative Approaches
February 1, 2017and April 5, 2017 and available on demand through
October 5, 2017.
Posted by...Bernard Sklar, MD.
Free Diabetes CME Credit hours...2.0. (1,0 hour for each)
CME Credits Awarded by....Primary Care Network.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for endocrinologists, primary care clinicians, physician assistants, nurse practitioners, pharmacists, certified diabetes educators and other health care providers who provide frontline glycemic management for type 2 diabetes and related conditions.
Educational material updated....April 5, 2017.
Expiration of CME credit...October 5, 2017.
Financial Support...Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.
After viewing the two presentations of Basal Insulin as a Foundation of Diabetes
, you will be
better able to:
• Describe the pharmacokinetics and pharmacodynamics of the newer ultra-long basal and follow-on biologic
("biosimilar") insulin formulations and how these differ from older formulations
• Determine indications and methods to transition from analog basal insulin to ultra-long basal insulins and follow-on biologic
("biosimilar") basal insulins to help achieve individualized patient treatment goals
• Examine the evidence-based, guideline-driven protocols for therapeutic advancement to basal insulin therapy alone or in combination with other treatment modalities to achieve individualized patient goals
• Identify potential patient, provider, and health care system barriers to initiation and titration of established and newer basal insulins, and methods to overcome these barriers